{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:52:15Z","timestamp":1789678335894,"version":"4.0.1"},"reference-count":87,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>\n                    Resistance to the first-line antituberculosis (TB) drug isoniazid (INH) is widespread, and the mechanism of resistance is unknown in approximately 15% of INH-resistant (INH-R) strains. To improve molecular detection of INH-R TB, we used whole-genome sequencing (WGS) to analyze 52 phenotypically INH-R\n                    <jats:named-content content-type=\"genus-species\">Mycobacterium tuberculosis<\/jats:named-content>\n                    complex (MTBC) clinical isolates that lacked the common\n                    <jats:italic>katG<\/jats:italic>\n                    S315T or\n                    <jats:italic>inhA<\/jats:italic>\n                    promoter mutations.\n                  <\/jats:p>","DOI":"10.1128\/aac.00974-18","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T05:42:37Z","timestamp":1533620557000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":29,"title":["Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests"],"prefix":"10.1128","volume":"62","author":[{"given":"Justin L.","family":"Kandler","sequence":"first","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra D.","family":"Mercante","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Dalton","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Ezewudo","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Critical Path Institute, Tucson, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren S.","family":"Cowan","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Burns","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Metchock","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of Global PETTS Investigators Martie van der Walt South Africa Medical Research Council Pretoria, South Africa Jeannette Brand South Africa Medical Research Council Pretoria, South Africa Thelma Tupasi Tropical Disease Foundation, Manila, Philippines Janice Caoili Tropical Disease Foundation, Manila, Philippines M. Tarcela Gler Tropical Disease Foundation, Manila, Philippines Carmen Contreras Socios en Salud Sucursal, Lima, Peru Martin Yagui Socios en Salud Sucursal, Lima, Peru Jaime Bayona Socio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cegielski","sequence":"additional","affiliation":[{"name":"Division of Global HIV &amp; TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Posey","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"World Health Organization","author":"WHO","year":"2017","unstructured":"WHO. 2017. Global tuberculosis report. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/259366\/1\/9789241565516-eng.pdf?ua=1. Accessed 16 November 2017."},{"key":"e_1_3_3_3_2","unstructured":"IHME. 2015. Financing global health 2014: shifts in funding as the MDG era closes. http:\/\/www.healthdata.org\/sites\/default\/files\/files\/policy_report\/2015\/FGH2014\/IHME_PolicyReport_FGH_2014_1.pdf. Accessed 16 November 2017."},{"key":"e_1_3_3_4_2","volume-title":"Global tuberculosis report","author":"WHO","year":"2015","unstructured":"WHO. 2015. Global tuberculosis report. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed 7 September 2016."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.2.1.29"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw376"},{"key":"e_1_3_3_7_2","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"WHO","year":"2018","unstructured":"WHO. 2018. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260233\/9789241550239-eng.pdf;jsessionid=3991C5ADD5F3F12C489193C71F88555E?sequence=1. Accessed 19 April 2018."},{"key":"e_1_3_3_8_2","volume-title":"WHO model list of essential medicines","author":"WHO","year":"2015","unstructured":"WHO. 2015. WHO model list of essential medicines. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EML_2015_FINAL_amended_NOV2015.pdf?ua=1. Accessed 8 May 2017."},{"key":"e_1_3_3_9_2","volume-title":"WHO model list of essential medicines for children","author":"WHO","year":"2015","unstructured":"WHO. 2015. WHO model list of essential medicines for children. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EMLc_2015_FINAL_amended_AUG2015.pdf?ua=1. Accessed 8 May 2017."},{"key":"e_1_3_3_10_2","volume-title":"Core curriculum on tuberculosis","author":"CDC","year":"2016","unstructured":"CDC. 2016. Core curriculum on tuberculosis. Centers for Disease Control and Prevention, Atlanta, GA. http:\/\/www.cdc.gov\/tb\/education\/corecurr\/pdf\/chapter6.pdf. Accessed 8 May 2017."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022927"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30407-8"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3767"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MGM2-0014-2013"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119628"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/514096"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.4955-4960.2002"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1466"},{"key":"e_1_3_3_19_2","first-page":"1347","article-title":"First documentation of isoniazid reversion in Mycobacterium tuberculosis","volume":"13","author":"Richardson ET","year":"2009","unstructured":"Richardson ET, Lin SY, Pinsky BA, Desmond E, Banaei N. 2009. First documentation of isoniazid reversion in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13:1347\u20131354.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp237"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/358591a0"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2011.07547.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03277-14"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.12476"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2016.09.004"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2.5.583"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.12.5463"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5375.363"},{"key":"e_1_3_3_29_2","volume-title":"The use of molecular line probe assay for the detection of resistance to isoniazid and rifampicin: policy update","author":"WHO","year":"2016","unstructured":"WHO. 2016. The use of molecular line probe assay for the detection of resistance to isoniazid and rifampicin: policy update. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/250586\/1\/9789241511261-eng.pdf?ua=1. Accessed 5 May 2017."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00521-07"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05638-11"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01550-10"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60734-X"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0164-0"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.42"},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5603\/ARM.34789","article-title":"Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"81","author":"Jagielski T","year":"2013","unstructured":"Jagielski T, Grzeszczuk M, Kaminski M, Roeske K, Napiorkowska A, Stachowiak R, Augustynowicz-Kopec E, Zwolska Z, Bielecki J. 2013. Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Pneumonol Alergol Pol 81:298\u2013307.","journal-title":"Pneumonol Alergol Pol"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268813002409"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.1075-1078.2006"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00309-08"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt090"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010597"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.496"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2735"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.9.3373-3381.2004"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm054"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.324"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000002"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02499-08"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.13.4033-4039.2001"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13212"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt358"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5812"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2472"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1006\/jtbi.1995.0122"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2008.06109.x"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01054-06"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1996.00133.x"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta19340"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00417-14"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.49"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00486-15"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02483-16"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep46327"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00358-17"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10063"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.07.007"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00466-X"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00298-17"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17705-3"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1995.mmi_17050889.x"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2878"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00112-06"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2174"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00536-10"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026038"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01791-14"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.4.1455-1464.2005"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/31159"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix169"},{"key":"e_1_3_3_80_2","volume-title":"WHO treatment guidelines for drug-resistant tuberculosis","author":"WHO","year":"2016","unstructured":"WHO. 2016. WHO treatment guidelines for drug-resistant tuberculosis. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/250125\/1\/9789241549639-eng.pdf?ua=1. Accessed 18 October 2017."},{"key":"e_1_3_3_81_2","volume-title":"Ph.D. dissertation","author":"van Kessel JC","year":"2008","unstructured":"van Kessel JC. 2008. Recombineering in Mycobacteria using mycobacteriophage proteins. Ph.D. dissertation, University of Pittsburgh, Pittsburgh, PA."},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04438-14"},{"key":"e_1_3_3_83_2","volume-title":"Approved standard","author":"CLSI","year":"2011","unstructured":"CLSI. 2011. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes. Approved standard, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1382-z"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12833"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-232-8_15"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2016.04.010"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05903-11"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00974-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00974-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T17:31:14Z","timestamp":1661707874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00974-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":87,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1128\/AAC.00974-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.00974-18","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/322750","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00974-18"}}